Improving glomerular filtration rate estimation by semi-supervised learning: a development and external validation study
- PMID: 33710531
- DOI: 10.1007/s11255-020-02771-w
Improving glomerular filtration rate estimation by semi-supervised learning: a development and external validation study
Abstract
Background: Accurate estimating glomerular filtration rate (GFR) is crucial both in clinical practice and epidemiological survey. We incorporated semi-supervised learning technology to improve GFR estimation performance.
Methods: AASK [African American Study of Kidney Disease and Hypertension], CRIC [Chronic Renal Insufficiency Cohort] and DCCT [Diabetes Control and Complications Trial] studies were pooled together for model development, whereas MDRD [Modification of Diet in Renal Disease] and CRISP [Consortium for Radiological Imaging Studies of Polycystic Kidney Disease] studies for model external validation. A total of seven variables (Serum creatinine, Age, Sex, Black race, Diabetes status, Hypertension and Body Mass Index) were included as independent variables, while the outcome variable GFR was measured as the urinary clearance of 125I-iothalamate. The revised CKD-EPI [Chronic Kidney Disease Epidemiology Collaboration] creatinine equations was selected as benchmark for performance comparisons. Head-to-head performance comparisons from four-variable to seven-variable combination were conducted between revised CKD-EPI equations and semi-supervised models.
Results: In each independent variables combination, the semi-supervised models consistently achieved superior results in all three performance indicators compared with corresponding revised CKD-EPI equations in the external validation data set. Furthermore, compared with revised four-variable CKD-EPI equation, the seven-variable semi-supervised model performed less biased (mean of difference: 0.03 [- 0.28, 0.34] vs 1.53 [1.28, 1.85], P < 0.001), more precise (interquartile range of difference: 7.94 [7.37, 8.50] vs 8.28 [7.76, 8.83], P = 0.1) and accurate (P30: 88.9% [87.4%, 90.2%] vs 86.0% [84.4%, 87.4%], P < 0.001.
Conclusions: The superior performance of the semi-supervised models during head-to-head comparisons supported the hypothesis that semi-supervised learning technology could improve GFR estimation performance.
Keywords: Chronic kidney disease (CKD); Estimating equation; Glomerular filtration rate (GFR); Semi-supervised learning; Serum creatinine.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Estimation of GFR in South Asians: a study from the general population in Pakistan.Am J Kidney Dis. 2014 Jan;63(1):49-58. doi: 10.1053/j.ajkd.2013.07.023. Epub 2013 Sep 26. Am J Kidney Dis. 2014. PMID: 24074822 Free PMC article.
-
Accuracy and precision of the CKD-EPI and MDRD predictive equations compared with glomerular filtration rate measured by inulin clearance in a Saudi population.Ann Saudi Med. 2016 Mar-Apr;36(2):128-34. doi: 10.5144/0256-4947.2016.28.3.1715. Epub 2016 Mar 28. Ann Saudi Med. 2016. PMID: 27018810 Free PMC article.
-
GFR estimation: from physiology to public health.Am J Kidney Dis. 2014 May;63(5):820-34. doi: 10.1053/j.ajkd.2013.12.006. Epub 2014 Jan 28. Am J Kidney Dis. 2014. PMID: 24485147 Free PMC article. Review.
-
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.Am J Kidney Dis. 2010 Jul;56(1):39-49. doi: 10.1053/j.ajkd.2010.02.347. Am J Kidney Dis. 2010. PMID: 20537455 Free PMC article. Clinical Trial.
-
Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate.J Nephrol. 2014 Oct;27(5):467-75. doi: 10.1007/s40620-014-0087-7. Epub 2014 Apr 8. J Nephrol. 2014. PMID: 24711159 Review.
Cited by
-
High Serum Levels of Irisin, Visfatin and Adiponectin as Potential Independent Risk Factors for Diabetic Nephropathy Progression in Patients With Type 2 Diabetes Mellitus.In Vivo. 2025 May-Jun;39(3):1615-1624. doi: 10.21873/invivo.13962. In Vivo. 2025. PMID: 40294981 Free PMC article.
References
-
- Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic Kidney Disease. Lancet 389(10075):1238–1252. https://doi.org/10.1016/S0140-6736(16)32064-5 - DOI - PubMed
-
- Glassock RJ, Warnock DG, Delanaye P (2016) The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol 13:104. https://doi.org/10.1038/nrneph.2016.163 - DOI - PubMed
-
- Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang J-e, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822. https://doi.org/10.1016/S0140-6736(12)60033-6 - DOI - PubMed
-
- Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, Coresh J, Zhao M-H, Wang H (2016) Trends in Chronic Kidney Disease in China. N Engl J Med 375(9):905–906. https://doi.org/10.1056/NEJMc1602469 - DOI - PubMed
-
- Levey AS, Inker LA (2016) GFR as the “Gold Standard”: Estimated, Measured, and True. Am J Kidney Dis 67(1):9–12. https://doi.org/10.1053/j.ajkd.2015.09.014 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical